Aortic Stenosis WritingGroupBonowROBrownAS, et al.ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Soc Echocardiogr2018; 31: 117–147.
2.
CullerSDCohenDJBrownPP, et al.Trends in aortic valve replacement procedures between 2009 and 2015: Has transcatheter aortic valve replacement made a difference?Ann Thorac Surg2018; 105: 1137–1143.
3.
Rodriguez-GabellaTVoisinePDagenaisF, et al.Long-term outcomes following surgical aortic bioprosthesis implantation. J Am Coll Cardiol2018; 71: 1401–1412.
4.
ChakosAWilson-SmithAAroraS, et al.Long term outcomes of transcatheter aortic valve implantation (TAVI): A systematic review of 5-year survival and beyond. Ann Cardiothorac Surg2017; 6: 432–443.
5.
NadirMAWeiLElderDH, et al.Impact of renin–angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol2011; 58: 570–576.
6.
InoharaTManandharPKosinskiAS, et al.Association of renin–angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement. JAMA2018; 320: 2231–2241.
7.
MagneJGuinotBLe GuyaderA, et al.Relation between renin–angiotensin system blockers and survival following isolated aortic valve replacement for aortic stenosis. Am J Cardiol2018; 121: 455–460.
8.
OchiaiTSaitoSYamanakaF, et al.Renin–angiotensin system blockade therapy after transcatheter aortic valve implantation. Heart2018; 104: 644–651.
9.
GoelSSAksoyOGuptaS, et al.Renin–angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: A cohort study. Ann Intern Med2014; 161: 699–710.
10.
LassniggAHiesmayrMFrantalS, et al.Long-term absolute and relative survival after aortic valve replacement: A prospective cohort study. Eur J Anaesthesiol2013; 30: 695–703.
11.
ImranHMBaigMMujibM, et al.Comparison of phase 2 cardiac rehabilitation outcomes between patients after transcatheter versus surgical aortic valve replacement. Eur J Prev Cardiol2018; 25: 1577–1584.
12.
RibeiroGSMeloRDDereszLF, et al.Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 688–697.
13.
DahlJSVidebaekLPoulsenMK, et al.Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis. Am J Cardiol2010; 106: 713–719.
14.
BullSLoudonMFrancisJM, et al.A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). Eur Heart J Cardiovasc Imaging2015; 16: 834–841.
15.
Amat-SantosIJCataláPDiez Del HoyoF, et al.Impact of renin–angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: Rationale and design of the RASTAVI randomized multicentre study. BMJ Open2018, pp. 8.
